These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks? Kapoor R; Shome D; Jain V; Dikshit R Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041 [TBL] [Abstract][Full Text] [Related]
6. Effect of botulinum toxin A on facial wrinkle lines in Koreans. Lew H; Yun YS; Lee SY; Kim SJ Ophthalmologica; 2002; 216(1):50-4. PubMed ID: 11901289 [TBL] [Abstract][Full Text] [Related]
7. The use of Botulinum toxin-a injection for facial wrinkles: a histological and immunohistochemical evaluation. El-Domyati M; Attia SK; El-Sawy AE; Moftah NH; Nasif GA; Medhat W; Marwan B J Cosmet Dermatol; 2015 Jun; 14(2):140-4. PubMed ID: 25916463 [TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives. Lowe NJ Dermatol Surg; 1998 Nov; 24(11):1216-8. PubMed ID: 9834741 [TBL] [Abstract][Full Text] [Related]
9. Are There Differences Between Intradermal and Intramuscular Injections of Botulinum Toxin on the Forehead? Kim YJ; Lim OK; Choi WJ Dermatol Surg; 2020 Dec; 46(12):e126-e131. PubMed ID: 32205751 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of people's satisfaction with botulinum toxin injection for facial rejuvenation based on age. Farashi F; Ghoncheh M; Ghasemian Moghaddam MR; Soroosh Z J Cosmet Dermatol; 2024 Jul; 23(7):2380-2385. PubMed ID: 38500014 [TBL] [Abstract][Full Text] [Related]
11. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Edelstein C; Shorr N; Jacobs J; Balch K; Goldberg R Dermatol Surg; 1998 Nov; 24(11):1208-12. PubMed ID: 9834740 [TBL] [Abstract][Full Text] [Related]
12. [Botulinum toxin injection techniques in the lower third and middle of the face, the neck and the décolleté: the "Nefertiti lift"]. Gassia V; Beylot C; Béchaux S; Michaud T Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S111-8. PubMed ID: 19576476 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin below the eyes. Carruthers J; Carruthers A Int Ophthalmol Clin; 2005; 45(3):133-41. PubMed ID: 15970772 [No Abstract] [Full Text] [Related]
14. Botulinum A toxin for glabellar wrinkles. Dose and response. Hankins CL; Strimling R; Rogers GS Dermatol Surg; 1998 Nov; 24(11):1181-3. PubMed ID: 9834736 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines. Brandt F; O'Connell C; Cazzaniga A; Waugh JM Dermatol Surg; 2010 Dec; 36 Suppl 4():2111-8. PubMed ID: 21134043 [TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction. Sepehr A; Chauhan N; Alexander AJ; Adamson PA Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497 [TBL] [Abstract][Full Text] [Related]
18. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures. Wollina U; Konrad H Am J Clin Dermatol; 2005; 6(3):141-50. PubMed ID: 15943491 [TBL] [Abstract][Full Text] [Related]
19. Multipoint and multilevel injection technique of botulinum toxin A in facial aesthetics. Iozzo I; Tengattini V; Antonucci VA J Cosmet Dermatol; 2014 Jun; 13(2):135-42. PubMed ID: 24910277 [TBL] [Abstract][Full Text] [Related]